MDx-Chex™ for BCID2

MDx-Chex for BCID2 is a first-of-its-kind quality control designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis. Provided in a comprehensive and easy-to-use format, MDx-Chex for BCID2 evaluates the entire analytical process of the test, including cell lysis, DNA extraction, purification and removal of PCR inhibitors, as well as qPCR amplification, detection and analysis. MDx-Chex for BCID2 can be used for assay verification, to track lot-to-lot performance of tests and to reduce the occurrence of incorrect results due to instrument or assay failures.

MDx-Chex for BCID2 is a patient-like full process control designed to validate the entire analytical process for sample-to-result tests. The control kit contains 43 bacteria, yeasts and antimicrobial resistance gene targets packaged in two separate vials, one for Gram (-) bacteria and one for the Gram (+) bacteria and yeasts, covering targets commonly tested for in molecular sepsis tests. The microorganisms are intact, inactivated and suspended in a matrix of stabilized red blood cells, white blood cells and blood culture media components, which is designed to challenge the lysis and purification processes just like a patient sample.

Show More
Using MDx-Chex for BCID2

For Research Use Only. Not for use in diagnostic procedures.

Features

  • Comprised of inactivated microorganisms in a matrix of blood cells and culture media components to simulate a patient sample.
  • Two sample-to-result tests needed for complete coverage of all 43 targets,  which are contained in two vials.
  • Allows for direct use on the sample-to-result test platform.

Benefits

  • Challenges and verifies the entire analytical process of MDx-based sepsis assays.
    • Cell lysis
    • DNA extraction/purification
    • PCR inhibition
    • Detection analysis
    • Results reporting
  • Saves the use of expensive sample-to-result cartridges.
    • Use 2 cartridges vs. 6 cartridges.
    • Provides complete target coverage.
  • Easy to use.
    • Pipette like a patient sample from a blood culture bottle.
    • No pooling of individual microorganisms needed.
  • Reduces preanalytical variables.
    • Pipetting errors
    • Cross-contamination

Product Information

DescriptionCatalog Number
 
MDx-Chex for BCID2250059

Order MDx-Chex for BCID2 today

New customers

Existing customers

International customers find a distributor

Streck’s antibiotic resistance monitoring and detection (ARM-D) kits can be used as a part of a hospital’s surveillance program when screening patients and by identifying – in just a few hours – which Gram-negative resistant bacterial strains are present in the facility. Streck’s real-time PCR instrument and hot-start enzyme formulated for fast PCR can save your lab time without compromising results.

Streck ARM-D Kits

The latest from the blog

Molecular

A link between AMR and COVID-19

Several recent publications and communications from infectious disease experts have illustrated what has been called the hidden threat behind COVID-19…
Read More
Molecular

Antimicrobial resistance in pets

Antimicrobial resistance (AMR) has become a significant public health issue globally, including in the United States. The issue is a worsening problem…
Read More
Molecular

AMR in the food chain

The food supply chain in the United States is among the safest in the world, but keeping it safe has become more challenging due to the rapidly evolvi…
Read More